Virus News and Research

Latest Virus News and Research

Sheep at low-risk for infection with SARS-CoV-2

A team of scientists from the US has recently evaluated the susceptibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in sheep. The findings reveal that sheep are generally less susceptible to SARS-CoV-2 infection. However, the susceptibility is relatively higher for the alpha variant of the virus. The study is currently available on the bioRxiv preprint server.

21 Nov 2021

Study explores connections between COVID-19 severity and gene expression in immune cells

New research shows how genetic variations linked to severe cases of COVID-19 affect our immune cells.

21 Nov 2021

People urged to take up life-saving COVID-19 booster vaccines ahead of Christmas

From tomorrow, the National Booking Service will open to people aged 40-49 for their booster jab, and young people aged 16-17 for their second jab.

21 Nov 2021

Booster or third dose for outbound international travel to be added to NHS COVID Pass

Travelers who have had a booster or a third dose will be able to demonstrate their vaccine status through the NHS COVID Pass from Friday 19 November.

21 Nov 2021

Delta-like SARS-CoV-2 variants with enhanced transmissibility may cause a more severe pandemic

A SARS-CoV-2 variant with traits similar to that of the Delta variant - enhanced transmissibility and an ability to infect people who had previous infections/vaccination - will cause a more severe pandemic with more infections and breakthrough infections/reinfections than variants with either trait alone, according to a mathematical model created by researchers at Harvard T.H. Chan School of Public Health.

21 Nov 2021

Novel technique solves structure of the HIV capsid alone and in complex with host factors

A new technique using electron tomography and subtomogram averaging at Diamond's electron Bio-Imaging Centre (eBIC), has solved the structure of the HIV capsid alone and in complex with host factors.

21 Nov 2021

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors - a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions - generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

GABA secreted by B-cells blunts the body's cytotoxic T-cell-based response to tumors

A group of scientists led by researchers from the RIKEN Center for Integrative Medical Sciences have discovered that B-cells, a type of immune cell, secrete the neurotransmitter GABA, and also found that the GABA secreted by the B-cells promoted the emergence of anti-inflammatory macrophages, blunting the body's cytotoxic T-cell-based response to tumors.

21 Nov 2021

New evidence that host immunity drives evolution of the dengue virus

New research by a team of University of Florida investigators, and others, provides evidence that host immunity drives evolution of the dengue virus.

20 Nov 2021

Creating a timeline that details the earliest COVID-19 cases in Wuhan

In a Perspective, Michael Worobey provides an overview of the crucial events that occurred between December 2019 and January 2020 in Wuhan, China, creating a timeline detailing the earliest cases of COVID-19, their connections to the Hunan Market where live animals were sold, and the events that led to SARS-CoV-2's formal identification as a novel virus.

20 Nov 2021

Trial positions single-dose HPV vaccination as a high impact public health intervention

In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.

20 Nov 2021

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

Infection with respiratory syncytial virus during infancy results in metabolic reprogramming of epithelial cells lining the airway, according to a Northwestern Medicine study published in the journal Viruses.

20 Nov 2021

CDC expands recommendations for COVID-19 booster dose to include all adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) expanded recommendations for booster shots to include all adults ages 18 years and older who received a Pfizer-BioNTech or Moderna vaccine at least six months after their second dose.

19 Nov 2021

Risk of adverse pregnancy outcomes from SARS-CoV-2 likely lower than previously suggested

The risk of adverse pregnancy outcomes in women who tested positive for SARS-CoV-2 is likely lower than several earlier studies have suggested, a national study of all pregnant Swedish women tested for SARS-CoV-2 between March 2020 and January 2021 reports.

19 Nov 2021

Effectiveness of COVID-19 vaccination during Delta variant predominance

A new study investigated the continued effectiveness of COVID-19 vaccination during the delta variant predominance in a diverse and urban healthcare setting.

19 Nov 2021

Functions of glycosylation in SARS-CoV-2 proteins and human receptor ACE2

In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.

19 Nov 2021

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Researchers from Sorbonne Université have been reviewing papers exploring different anti-COVID-19 drugs.

19 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

Predicting the capacity of mammal species to become zoonotic SARS-CoV-2 hosts

Researchers identified a subset of species in which the threat of spillback infection appears the most significant due to location and increased contact with humans in areas with a high prevalence of SARS-CoV-2.

19 Nov 2021

Vaccine-or-test requirements increase work and costs for governments

Amanda Kostroski, a 911 dispatcher in Madison, Wisconsin, leaves her busy job once a week to go to a county health clinic to be tested for covid-19.

19 Nov 2021

Virus News and Research

Latest Virus News and Research

Sheep at low-risk for infection with SARS-CoV-2

Study explores connections between COVID-19 severity and gene expression in immune cells

People urged to take up life-saving COVID-19 booster vaccines ahead of Christmas

Booster or third dose for outbound international travel to be added to NHS COVID Pass

Delta-like SARS-CoV-2 variants with enhanced transmissibility may cause a more severe pandemic

Novel technique solves structure of the HIV capsid alone and in complex with host factors

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

GABA secreted by B-cells blunts the body's cytotoxic T-cell-based response to tumors

New evidence that host immunity drives evolution of the dengue virus

Creating a timeline that details the earliest COVID-19 cases in Wuhan

Trial positions single-dose HPV vaccination as a high impact public health intervention

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

CDC expands recommendations for COVID-19 booster dose to include all adults

Risk of adverse pregnancy outcomes from SARS-CoV-2 likely lower than previously suggested

Effectiveness of COVID-19 vaccination during Delta variant predominance

Functions of glycosylation in SARS-CoV-2 proteins and human receptor ACE2

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

First long-acting injectable HIV treatment appraised and approved by NICE

Predicting the capacity of mammal species to become zoonotic SARS-CoV-2 hosts

Vaccine-or-test requirements increase work and costs for governments

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Virus News and Research

Latest Virus News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in